Norwegian Radium Hospital

This article has been updated from a version posted Feb. 22 to include comments from an OGT executive.

According to the study's findings, the major vendors' platforms performed well in terms of reproducibility, but Agilent's microarrays showed better linearity and dynamic range.

Using gene dosage, expression, and ontology data, the researchers identified recurrent changes linked to cervical cancer development and treatment outcomes.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.